Straits Times Index
3,271.08 -5.28 (-0.16%) Nikkei
27,934.47 -93.37 (-0.33%) Hang Seng
18,245.04 +40.36 (+0.22%) FTSE 100
7,512.00 +37.98 (+0.51%) BTC-USD
16,857.94 +414.65 (+2.52%) CMC Crypto 200
400.43 +11.71 (+3.01%)
Aditxt, Inc. (ADTX)
After hours:
| Previous close | 1.7500 |
| Open | 1.7200 |
| Bid | 1.7500 x 1100 |
| Ask | 1.7700 x 3100 |
| Day's range | 1.7200 - 1.8000 |
| 52-week range | 1.5700 - 51.0000 |
| Volume | |
| Avg. volume | 2,883,769 |
| Market cap | 7.365M |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.7200 |
| Earnings date | 13 Nov 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 27.00 |
- Business Wire
Aditxt’s (Nasdaq: ADTX) Adimune™ Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI™-100 in Preparation for Planned Psoriasis First-in-Human Trials
RICHMOND, Va., October 21, 2022--Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces that its program Adimune™ has initiated the GMP manufacturing of drug candidate ADI™-100 as a key milestone toward its goal to begin first-in-human trials during the second half of 2023. Pending regulatory approvals, these trials will be performed in autoimmun
- Business Wire
Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection
RICHMOND, Va., October 12, 2022--Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces publication of a mathematical model for predicting the durability and rate of decay of neutralizing antibodies to SARS-CoV-2 in a peer-reviewed research paper in the Journal of Theoretical Biology.
- Business Wire
FedEx Features AditxtScore™ Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of Quantifying Immune Health
RICHMOND, Va., October 07, 2022--Aditxt, Inc.’s (NASDAQ: ADTX) ("Aditxt", or the "Company") AditxtScore™ is featured by FedEx in a video presentation that showcases the various ways in which both companies are playing critical roles in a challenging environment that includes the nation’s response to COVID-19.
